Modified cap group suberoylanilide hydroxamic acid histone deacetylase inhibitor derivatives reveal improved selective antileukemic activity.

Source:http://linkedlifedata.com/resource/pubmed/id/20218673

J. Med. Chem. 2010 Apr 22 53 8 3038-47

Download in:

View as

Triples

General Info

PMID
20218673